Intervention not reported
Ribavirin vs.interferon · Participants with recurrent liver graft infection with hepatitis C virus.
1 finding from 1 review
Intervention not reported
Ribavirin vs.placebo · Participants with recurrent liver graft infection with hepatitis C virus.
1 finding from 1 review
Intervention not reported
Retransplantation after start of therapy ‐ ribavirin vs.placebo · Participants with recurrent liver graft infection with hepatitis C virus.
1 finding from 1 review
Intervention not reported
Retransplantation after start of therapy ‐ interferon vs.control · Participants with recurrent liver graft infection with hepatitis C virus.
It is very uncertain whether the intervention changes retransplantation after start of therapy ‐ interferon vs.control (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events ‐ Haemodilution versus control. · patients with liver resection.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number requiring allogeneic blood transfusion ‐ Low central venous pressure (CVP) versus control. · patients with liver resection.
It is very uncertain whether the intervention changes number requiring allogeneic blood transfusion ‐ Low central venous… (very low certainty).
1 finding from 1 review
Intervention not reported
Number requiring allogeneic blood transfusion ‐ Haemodilution versus control. · patients with liver resection.
The intervention led to lower number requiring allogeneic blood transfusion ‐ Haemodilution versus…; GRADE not reported.
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Low CVP versus control. · patients with liver resection.
1 finding from 1 review
Intervention not reported
Red cell transfusion ‐ Haemodilution versus control. · patients with liver resection.
1 finding from 1 review
Re‐hospitalisation post liver transplantation [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Acute rejection · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
New onset of diabetes · adult patients with malnutrition and encephalopathy before and after liver transplantation.
It is very uncertain whether standard casein product (Ensure) changes new onset of diabetes compared with diet only (without supplement) (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Hepatic encephalopathy related hospitalisation · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Changes in grade of hepatic encephalopathy [grade 0‐4] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Mortality during time on waiting list (ITT) · adult patients before and after liver transplantation.
It is very uncertain whether nutritional supplement (500ml) and standard diet changes mortality during time on waiting list (ITT) compared with standard diet alone (very low certainty).
1 finding from 1 review
Six months mortality after liver transplantation (ITT) · adult patients before and after liver transplantation.
It is very uncertain whether nutritional supplement (500ml) and standard diet changes six months mortality after liver transplantation (ITT) compared with standard diet alone (very low certainty).
1 finding from 1 review
Mild acute rejection episodes (within 6 months after LTx) · adult patients before and after liver transplantation.
It is very uncertain whether nutritional supplement (500ml) and standard diet changes mild acute rejection episodes (within 6 months after LTx) compared with standard diet alone (very low certainty).
1 finding from 1 review
Severe acute rejection episodes (within six months after LTx) · adult patients before and after liver transplantation.
It is very uncertain whether nutritional supplement (500ml) and standard diet changes severe acute rejection episodes (within six months after LTx) compared with standard diet alone (very low certainty).
1 finding from 1 review
Immunological rejection episodes · adult patients after liver transplantation.
It is very uncertain whether enteral immunonutrion with Supportan changes immunological rejection episodes compared with enteral nutrition (EN) with Fresubin (very low certainty).
1 finding from 1 review